Cardiopulmonary Resuscitation Outcomes in Patients with Pulmonary Arterial Hypertension (PAH)

被引:0
|
作者
Mathers, H. [1 ]
Pebley, N. B. [1 ]
Odish, M. F. [2 ]
Papamatheakis, D. G. [2 ]
Poch, D. S. [2 ]
Kim, N. H. [2 ]
Fernandes, T. M. [2 ]
Wardi, G. [2 ]
Sell, R. E. [2 ]
机构
[1] Univ Calif San Diego UC San Diego, Sch Med, La Jolla, CA USA
[2] Univ Calif San Diego UC San Diego, Div Pulm Crit Care & Sleep Med, La Jolla, CA USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A2922
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
    Stratev, Velin
    Dobreva, Tanya
    Dimitrova, Valentina
    Petkova, Diana
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [32] Thyroid disease and pulmonary arterial hypertension (PAH) in patients treated with prostacyclin
    Ferris, AM
    Morse, JH
    Jacobs, T
    Rosenzweig, EB
    Aranoff, GS
    Barst, RJ
    CIRCULATION, 2000, 102 (18) : 426 - 427
  • [33] Cardiopulmonary rehabilitation in pulmonary arterial hypertension
    Von Oetinger, Astrid
    Maria Trujillo, Luz
    Villanueva, Sergio
    Zagolin, Monica
    REVISTA MEDICA DE CHILE, 2018, 146 (05) : 627 - 635
  • [34] Pulmonary Arterial Hypertension and Cardiopulmonary Comorbidities
    Gruenig, Ekkehard
    Benjamin, Nicola
    Echampati, Ishan
    Xanthouli, Panagiota
    AKTUELLE KARDIOLOGIE, 2023, 12 (01) : 51 - 56
  • [35] Reproducibility of cardiopulmonary exercise measurements in patients with pulmonary arterial hypertension
    Hansen, JE
    Sun, XG
    Yasunobu, Y
    Garafano, RP
    Gates, G
    Barst, RJ
    Wasserman, K
    CHEST, 2004, 126 (03) : 816 - 824
  • [36] Riociguat Dose Titration in Patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH) or Pulmonary Arterial Hypertension (PAH)
    Ghofrani, H. A.
    Hoeper, M. M.
    Hoeffken, G.
    Halank, M.
    Weimann, G.
    Grimminger, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [37] Treatment pathways in Finnish patients with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension (CTEPH)
    Pentikainen, Markku
    Simonen, Piia
    Leskela, Pauliina
    Harju, Terttu
    Jaaskelainen, Pertti
    Asseburg, Christian
    Oksanen, Minna
    Soini, Erkki
    Wennerstrom, Christina
    Puhakka, Airi
    FINPAH Study Grp
    PULMONARY CIRCULATION, 2025, 15 (01)
  • [38] A Meta-analysis: Outcomes in Patients With Pulmonary Arterial Hypertension (PAH) Associated With Congenital Heart Disease (CHD) Receiving PAH Medication
    Krasuski, R. A.
    Tobore, T.
    Studer, S.
    Jansa, P.
    Sitbon, O.
    Hoeper, M. M.
    Channick, R. N.
    Gaine, S.
    Lang, I. M.
    Chin, K. M.
    Pulido, T.
    Mehta, S.
    Torbicki, A.
    Sastry, B.
    Tang, X.
    McLaughlin, V.
    Reardon, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [39] PULMONARY HYPERTENSION ASSESSMENT AND RECOGNITION OF OUTCOMES IN SCLERODERMA (PHAROS): TWO-YEAR OUTCOMES FOR PRE-PULMONARY ARTERIAL HYPERTENSION (PAH)
    Hsu, V.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (02) : S76 - S76
  • [40] Pulmonary Involvement in Systemic Sclerosis and Pulmonary Arterial Hypertension (PAH)
    Graefenstein, K.
    AKTUELLE RHEUMATOLOGIE, 2011, 36 (01) : 47 - 53